This review highlights how foundation models enhance predictive healthcare by integrating advanced digital twin modeling with multiomics and biomedical data. This approach supports disease management, risk assessment, and personalized medicine, with the goal of optimizing health outcomes through adaptive, interpretable digital simulations, accessible ...
Sakhaa Alsaedi+2 more
wiley +1 more source
Estimating the treatment effects of multiple drug combinations on multiple outcomes in hypertension. [PDF]
Liu R, Li L, Zhang P.
europepmc +1 more source
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik+3 more
wiley +1 more source
High-throughput approaches to uncover synergistic drug combinations in leukemia. [PDF]
Chory EJ+17 more
europepmc +1 more source
Assessing synergy or antagonism for drug combinations
Angus Bell, Stella G. Machado
openalex +1 more source
Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro - In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus [PDF]
Joseph Meletiadis+3 more
openalex +1 more source
Gut alterations in a chronic kidney disease rat model with diet‐induced vascular calcification
Chronic kidney disease (CKD) patients often suffer from intestinal and/or mineral and bone disorders. Using a rat model, we showed that uremic vascular calcification is associated with gut barrier alterations (decreased gut mucus production and Nlrp6 gene expression, increased gut inflammation), and plasma retention of gut‐origin uremic toxins (indoxyl
Piotr Bartochowski+13 more
wiley +1 more source
Cancer Cell's Achilles Heels: Considerations for Design of Anti-Cancer Drug Combinations. [PDF]
Gahramanov V+8 more
europepmc +1 more source
DeepTraSynergy: drug combinations using multimodal deep learning with transformers. [PDF]
Rafiei F+5 more
europepmc +1 more source